Lexeo Therapeutics (LXEO) Treasury Shares (2024 - 2026)

Lexeo Therapeutics has disclosed Treasury Shares across 3 years of filings, most recently posting $17000.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $17000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $17000.0 (changed 0.0% YoY), and the FY2025 annual result was $17000.0, changed 0.0% from the prior year.
• Treasury Shares came in at $17000.0 for Q1 2026 at Lexeo Therapeutics, roughly flat from $17000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $738291.0 in Q2 2025 to a low of $2991.0 in Q2 2024.
• The 3-year median for Treasury Shares is $224945.0 (2024), against an average of $282595.1.
• Peak annual rise in Treasury Shares reached 30.77% in 2025, while the deepest fall reached 0.0% in 2025.
• Lexeo Therapeutics' Treasury Shares stood at $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025, then changed by 0.0% to $17000.0 in 2026.
• The last three Treasury Shares figures came in at $17000.0 (Q1 2026), $17000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.